BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14686878)

  • 1. N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.
    Tsuboi K; Hilligsmann C; Vandevoorde S; Lambert DM; Ueda N
    Biochem J; 2004 Apr; 379(Pt 1):99-106. PubMed ID: 14686878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A second N-acylethanolamine hydrolase in mammalian tissues.
    Ueda N; Tsuboi K; Lambert DM
    Neuropharmacology; 2005 Jun; 48(8):1079-85. PubMed ID: 15910884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
    Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
    Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase.
    Saturnino C; Petrosino S; Ligresti A; Palladino C; De Martino G; Bisogno T; Di Marzo V
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1210-3. PubMed ID: 20022504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase.
    Yamano Y; Tsuboi K; Hozaki Y; Takahashi K; Jin XH; Ueda N; Wada A
    Bioorg Med Chem; 2012 Jun; 20(11):3658-65. PubMed ID: 22542283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Tsuboi K; Takezaki N; Ueda N
    Chem Biodivers; 2007 Aug; 4(8):1914-25. PubMed ID: 17712833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
    Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
    Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
    Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
    Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance.
    Ueda N; Yamanaka K; Yamamoto S
    J Biol Chem; 2001 Sep; 276(38):35552-7. PubMed ID: 11463796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
    Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
    J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies.
    Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N
    Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
    Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
    J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening for the discovery of inhibitors of fatty acid amide hydrolase using a microsome-based fluorescent assay.
    Wang Y; Ramirez F; Krishnamurthy G; Gilbert A; Kadakia N; Xu J; Kalgaonkar G; Ramarao MK; Edris W; Rogers KE; Jones PG
    J Biomol Screen; 2006 Aug; 11(5):519-27. PubMed ID: 16760367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization and in vitro activity of AZ513, a noncovalent, reversible, and noncompetitive inhibitor of fatty acid amide hydrolase.
    Scott CW; Tian G; Yu XH; Paschetto KA; Wilkins DE; Meury L; Cao CQ; Varnes J; Edwards PD
    Eur J Pharmacol; 2011 Sep; 667(1-3):74-9. PubMed ID: 21645511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
    Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.
    Vandevoorde S; Tsuboi K; Ueda N; Jonsson KO; Fowler CJ; Lambert DM
    J Med Chem; 2003 Oct; 46(21):4373-6. PubMed ID: 14521402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
    Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.
    Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N
    J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates.
    Muccioli GG; Fazio N; Scriba GK; Poppitz W; Cannata F; Poupaert JH; Wouters J; Lambert DM
    J Med Chem; 2006 Jan; 49(1):417-25. PubMed ID: 16392827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.
    Minkkilä A; Myllymäki MJ; Saario SM; Castillo-Melendez JA; Koskinen AM; Fowler CJ; Leppänen J; Nevalainen T
    Eur J Med Chem; 2009 Jul; 44(7):2994-3008. PubMed ID: 19232787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.